Dyax Coporation, (
Q3 2010 Earnings Conference Call
October 27, 2010 05:00 pm ET
Gustav Christiansen – President, CEO
Ivana Magovčević-Liebisch - EVP, Corporate Development & General Counsel.
George Miguasky - Executive Vice President, CFO.
William Pullman - Executive Vice President, Chief Research and Development Officer.
Rick Berard - Vice President Commercial
Mark Monet - Needham Company
Phil Nato - Cohen and Company
Brian Scorny - Bank Equity
Kim Lee - Global Hunter Securities
Michael Smith - Unknown Company
Mario Corso - Harris and Company
Good morning afternoon and welcome Ladies and Gentlemen to Dyax Corps Third Quarter 2010 financial earnings conference call. At this time I would like to inform you that this conference call is being recorded and that all participants are in a listen only mode. As a request of the company we will open up the call for a question and answer period at the end of the presentation. Before turning this call over to Gustav Christiansen, President and Chief Executive Officer of Dyax, the company will read their safe harbor statement.
Unidentified Corporate Participant
This afternoon Dyax issued a press release concerning its third quarter 2010 financial results. Dyax would like to remind everyone that statements made today reflect current information, estimates and projections, about its products, programs, collaborations, strategies and financial performance in our forward-looking statements. These statements including those relating to Dyax's FDA approved products, KALBITOR, are subject to risks and uncertainties that could cause actual events to result to differ materially. Important information concerning these risks and uncertainties is contained in Dyax's press release today and is scribed or referred to as most recent form 10-K and other periodic reports filed with the SEC. And also available on the company's website at
. I will now turn the call over to Gustav Christiansen, our President and CEO. Gustav?
Thank you, Nicole. Good evening and thank you for joining us on the Dyax Quarterly Conference Call. With me this evening are Ivana Magovčević-Liebisch, our Executive Vice President, Corporate Development and General Counsel. George Miguasky, Executive Vice President and Chief Financial Officer, Bill Pullman, Executive Vice President and Chief Research and Development Officer and Rick Berard, Vice President Commercial. So third quarter was another defining quarter for Dyax. We continue to execute according to plans and as a result we witnessed our patient base grow dramatically.